XML 23 R12.htm IDEA: XBRL DOCUMENT v3.21.2
Note 5 - Restructuring and Other Exit Costs
 9 Months Ended
Sep. 30, 2021
Notes to Financial Statements  
Restructuring and Related Activities Disclosure [Text Block]

5.

Restructuring and Other Exit Costs

 

On an ongoing basis, the Company reviews the global economy, the healthcare industry, and the markets in which it competes to identify operational efficiencies, enhance commercial capabilities, and align its cost base and infrastructure with customer needs and its strategic plans. In order to realize these opportunities, the Company undertakes restructuring-type activities from time to time to transform its business.

 

The following table summarizes the changes in the restructuring liabilities for the nine months ended September 30, 2021:

 

(in thousands)

 

Severance

  

Other

  

Total

 

Balance at December 31, 2020

 $270  $18  $288 

Restructuring and other exit costs

  1,160   116   1,276 

Non-cash charges

  -   (41)  (41)

Cash payments

  (1,319)  (93)  (1,412)

Balance at September 30, 2021

 $111  $-  $111 

 

The restructuring liability has been included in other current liabilities in the consolidated balance sheet and is payable within the next twelve months. Restructuring costs were $0.1 million and $0.3 million for the three months ended September 30, 2021 and 2020, respectively. Restructuring costs were $1.3 million and $1.9 million for the nine months ended September 30, 2021 and 2020, respectively. Substantially all of these restructuring costs have been included as a component of general and administrative expenses.